Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Wight · SciRah

Researcher profile · Semantic Scholar

J. Wight

Share profile

J. Wight — researcher profile on SciRah

h-index: 12
Works: 53
Citations: 464

Most-cited papers

EBV-tissue positive primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity.
M. Gandhi, T. Hoang, S. Law, S. Brosda +24 more
2020Blood81 citations Open access
Semantic Scholar
Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI.
J. Wight, G. Chong, A. Grigg, E. Hawkes
2018Blood reviews66 citations
Semantic Scholar
Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID‐19 pandemic
Pietro R. Di Ciaccio, G. McCaughan, J. Trotman, P. Ho +29 more
2020Internal medicine journal (Print)41 citations Open access
Semantic Scholar
Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes
P. Blombery, L. Fox, G. Ryland, E. Thompson +16 more
2020Haematologica30 citations Open access
Semantic Scholar
Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B‐cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance
J. Wight, Mi-Mi Yue, C. Keane, A. Johnston +13 more
2019British Journal of Haematology28 citations Open access
Semantic Scholar
Toxicity associated with high-dose intravenous methotrexate for hematological malignancies
J. Wight, M. Ku, Melissa Garwood, Duncan P. Carradice +4 more
2022Leukemia and Lymphoma19 citations
Semantic Scholar
Safety and Efficacy of Induction and Maintenance Avelumab Plus R-CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Analysis of the Phase II Avr-CHOP Study
E. Hawkes, G. Chong, Charmaine D. Smith, Sze T. Lee +15 more
202017 citations Open access
Semantic Scholar
Improving outcomes for patients with lymphoma: design and development of the Australian and New Zealand Lymphoma and Related Diseases Registry
M. Anderson, L. Berkahn, Che-Ah Y. Chan, Michael Dickinson +62 more
2022BMC Medical Research Methodology15 citations Open access
Semantic Scholar
COVID‐19 vaccination in haematology patients: an Australian and New Zealand consensus position statement
G. McCaughan, Pietro R. Di Ciaccio, M. Ananda-Rajah, N. Gilroy +31 more
2021Internal medicine journal (Print)15 citations Open access
Semantic Scholar
Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study
K. Manos, G. Chong, C. Keane, Sze T. Lee +16 more
2023Leukemia14 citations
Semantic Scholar
An abscopal effect may augment PD-1 inhibition in refractory classical Hodgkin lymphoma
J. Wight, E. Hawkes, S. Berlangieri, Richard Khor +1 more
2018Leukemia and Lymphoma14 citations
Semantic Scholar
Prognostic markers in core‐binding factor AML and improved survival with multiple consolidation cycles of intermediate‐/high‐dose cytarabine
A. Prabahran, M. Tacey, S. Fleming, A. Wei +8 more
2018European Journal of Haematology13 citations
Semantic Scholar
Chronic lymphocytic leukaemia Australasian consensus practice statement
M. Anderson, R. Bennett, X. Badoux, Giles Best +21 more
2023Internal medicine journal (Print)12 citations Open access
Semantic Scholar
Dapsone safety in hematology patients: Pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipients
K. Urbancic, Daisy Pisasale, J. Wight, J. Trubiano
2018Transplant Infectious Disease12 citations
Semantic Scholar
Infection risk and antimicrobial prophylaxis in bendamustine‐treated patients with indolent non‐Hodgkin lymphoma: An Australasian Lymphoma Alliance study
K. Manos, Leonid Churilov, A. Grigg, Pietro R. Di Ciaccio +13 more
2024British Journal of Haematology11 citations
Semantic Scholar
Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance
A. Barraclough, J. England, D. Villa, J. Wight +26 more
2023Haematologica11 citations Open access
Semantic Scholar
Systemic diffuse large B-cell lymphoma involving the central nervous system has high rates of defective antigen presentation and immune surveillance
J. Wight, P. Blombery, J. Lickiss, Melinda Burgess +8 more
2024Haematologica9 citations Open access
Semantic Scholar
Diffuse large B‐cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance
J. Wight, N. Hamad, B. Campbell, M. Ku +9 more
2021Internal medicine journal (Print)9 citations Open access
Semantic Scholar
Low flow: Selecting a limited flow cytometry panel where resources are constrained.
Alison Ross, Donna Rudd, J. Wight
2025Blood reviews8 citations Open access
Semantic Scholar
Predicting primary treatment failure using interim FDG‐PET scanning in diffuse large B‐cell lymphoma
J. Wight, S. Wai, E. Shen, Sze T. Lee +6 more
2021European Journal of Haematology7 citations Open access
Semantic Scholar
Sequential high‐dose methotrexate and cytarabine administration improves outcomes in real‐world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance
M. Tatarczuch, K. Lewis, A. Gunjur, B. Shaw +23 more
2024eJHaem5 citations Open access
Semantic Scholar
A Window Study of Acalabrutinib & Rituximab, Followed By Chemotherapy & Autograft (ASCT) in Fit Patients with Treatment Naïve Mantle Cell Lymphoma (MCL): First Report of the Investigator-Initiated Australasian Leukaemia & Lymphoma Group NHL33 ‘Wamm’ Trial
E. Hawkes, S. T. Lee, Leonid Churilov, T. Armytage +17 more
2023Blood5 citations Open access
Semantic Scholar
A Phase 2, Open-Label, Ascending Dose Study of Ker-050 for the Treatment of Anemia in Patients with Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes
D. Ross, A. Arbelaez, L. Chee, C. Fong +17 more
2021Blood4 citations Open access
Semantic Scholar
Prolonged Lymphopenia and Infection Risk Is Mitigated By Antimicrobial Prophylaxis in Patients with Indolent Non-Hodgkin Lymphoma (iNHL) Treated with Bendamustine +/- Anti-CD20 Antibody: The Australasian Lymphoma Alliance Experience
K. Manos, M. Lasica, A. Grigg, Pietro R. Di Ciaccio +14 more
20203 citations
Semantic Scholar
A Comparison of High-Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML
A. Schwarer, J. Butler, K. Jackson, A. Beligaswatte +11 more
2018HemaSphere3 citations Open access
Semantic Scholar
Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance
M. Lasica, Mary A Anderson, Alex Boussioutas, Gareth P. Gregory +11 more
2024Internal medicine journal (Print)2 citations
Semantic Scholar
Australasian Leukaemia & Lymphoma Group NHL32 Block PCNSL: An Open Label Phase II Study of Pembrolizumab Following Chemoimmunotherapy for Newly Diagnosed Primary Central Nervous System Lymphoma - Trial in Progress
M. Tatarczuch, C. Keane, Christina Brown, P. Giri +9 more
2024Blood2 citations
Semantic Scholar
AvR-CHOP: Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
E. Hawkes, K. Manos, Charmaine Smith, J. Hawking +14 more
2019Blood2 citations Open access
Semantic Scholar
Correlation of mutation status and morphological changes in essential thrombocythaemia and myelofibrosis.
Chong Chyn Chua, A. Omerod, J. Wight, S. Juneja +1 more
2018Pathology (Sydney)2 citations
Semantic Scholar
Distinct immune checkpoint landscapes in PCNSL and SCNSL revealed by single-nucleus profiling
Z. Hawula, Nella Tuczko, Melinda Burgess, Lucy Bradbury +5 more
2025Blood1 citations
Semantic Scholar
Expression of the cancer testis antigen PRAME is associated with response to immune checkpoint inhibitor and rituximab priming in treatment-naïve diffuse large B-cell lymphoma
K. Manos, Melinda Burgess, Geoffrey Chong, Sze T. Lee +14 more
2025Blood1 citations
Semantic Scholar
Real-world utilization of Bruton tyrosine kinase inhibitors in relapsed/refractory chronic lymphocytic leukemia in Australia
S. Mulligan, Philip A. Thompson, J. Wight, Mary Ann Anderson +4 more
2025Leukemia and Lymphoma1 citations Open access
Semantic Scholar
Obinutuzumab, Lenalidomide and Venetoclax for the Initial Treatment of Patients with Advanced-Stage Follicular Lymphoma: Primary Analysis of an Investigator-Initiated Phase Ib/II, Multicenter Study (LEVERAGE)
Che-Ah Y. Chan, A. Johnston, J. Wight, P. Blombery +7 more
2024Blood1 citations
Semantic Scholar
Australia and New Zealand consensus position statement: use of COVID‐19 therapeutics in patients with haematological malignancies
Ashlea Campbell, Benjamin W. Teh, S. Mulligan, D. M. Ross +24 more
2023Internal medicine journal (Print)1 citations Open access
Semantic Scholar
Coagulopathy is an under-recognised complication of acquired HLH
Serena Kosciejew, Edward Morris, J. Wight
2023BMJ Case Reports1 citations
Semantic Scholar
Case of the disappearing drusen.
A. Haider, J. Wight, I. Reddie
2022Canadian Journal of Ophthalmology-journal Canadien D Ophtalmologie1 citations
Semantic Scholar
Real-World Outcomes of Patients with Primary CNS Lymphoma (PCNSL): A Report from the Australasian Lymphoma Alliance (ALA)
M. Tatarczuch, K. Lewis, A. Gunjur, B. Shaw +22 more
2021Blood1 citations Open access
Semantic Scholar
High-Dose Cytarabine (HiDAC) Improves the Cure Rate of Patients with Newly Diagnosed Acute Myeloid Leukemia (AML): Is It Better to be Given As Induction Therapy or As Consolidation Therapy?
A. Schwarer, J. Wight, K. Jackson, A. Beligaswatte +11 more
20161 citations
Semantic Scholar
Australasian chronic lymphocytic leukaemia consensus statement: 2026 update
Sean McKeague, J. Czerwinski, X. Badoux, R. Bennett +24 more
2026Internal medicine journal (Print)0 citations Open access
Semantic Scholar
T‐Cell Receptor Repertoires Show Dynamic Variation Between Diagnosis and Relapse of Diffuse Large B‐Cell Lymphoma
J. Wight, Tom Witkowski, Colm Keane, Eliza A. Hawkes
2025eJHaem0 citations Open access
Semantic Scholar
Divergent immune programs in EBV⁺ PCNSL: A multiomic study of AR-PCNSL and cns-PTLD
Melinda Burgess, Z. Hawula, Sarah Kempe, Valentine Murigneux +13 more
2025Blood0 citations
Semantic Scholar
Multiomic dissection of immune-privileged DLBCL reveals divergent immune subtypes in testicular and primary central nervous system lymphoma
Melinda Burgess, Z. Hawula, Nella Tuczko, Sarah Kempe +13 more
2025Blood0 citations
Semantic Scholar
Biological Features of Response to Immune Checkpoint Inhibitor and Rituximab Priming in Diffuse Large B-Cell Lymphoma
Rakin Chowdhury, K. Manos, Melinda Burgess, G. Chong +14 more
2024Blood0 citations
Semantic Scholar
Multiomics Analysis of Paired Diagnosis and Relapse DLBCL Biopsies Shows a Reduction in T Cell Infiltration and Function at Relapse
F. Swain, Melinda Burgess, Sarah Kempe, M. Sabdia +12 more
2024Blood0 citations
Semantic Scholar
Gene expression and spatial transcriptomic analysis of paired diagnosis and relapse DLBCL biopsies show a reduction in T cell infiltration and function at relapse
F. Swain, M. Burgess, S. Kempe, M. Sabdia +10 more
2023Hematological Oncology0 citations Open access
Semantic Scholar
Obinutuzumab, Lenalidomide and Venetoclax in Patients with Treatment-Naïve Advanced-Stage Follicular Lymphoma: First Results of the Investigator-Initiated Phase Ib/II, Multicenter Leverage Study
Che-Ah Y. Chan, K. Lewis, R. Bennett, A. Johnston +6 more
2023Blood0 citations Open access
Semantic Scholar
P776: A PHASE 2, OPEN-LABEL, ASCENDING DOSE STUDY OF KER-050 FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH VERY LOW, LOW, OR INTERMEDIATE RISK MYELODYSPLASTIC SYNDROMES
S. Tan, A. Arbelaez, L. Chee, C. Fong +16 more
2022HemaSphere0 citations Open access
Semantic Scholar
Effects of Ker-050 on Iron Metabolism: Exploratory Analyses from an Ongoing Phase 2 Study in Patients with Myelodysplastic Syndromes
L. Chee, D. Ross, S. Tan, J. Wight +9 more
2022Blood0 citations Open access
Semantic Scholar
A Window Study of Acalabrutinib Plus Rituximab Followed By R-Dhaox (rituximab, dexamethasone, cytarabine, oxaliplatin) and Autologous Stem Cell Transplant (ASCT) in Fit Mantle Cell Lymphoma (MCL): The Australasian Leukaemia & Lymphoma Group (ALLG) NHL33 Wamm Trial
E. Hawkes, S. Agrawal, Sze T. Lee, J. Wight +14 more
2021Blood0 citations Open access
Semantic Scholar
Diagnosis and management of primary central nervous system lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance
C. Keane, N. Hamad, A. Barraclough, Y. Y. Lee +6 more
2021Internal medicine journal (Print)0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Hawkes×15
Invite
E. Hawkes — researcher profile on SciRah
M. Ku×13
Invite
M. Ku — researcher profile on SciRah
N. Hamad×12
Invite
N. Hamad — researcher profile on SciRah
A. Barraclough×10
Invite
A. Barraclough — researcher profile on SciRah

×9

Invite

C. Keane — researcher profile on SciRah

Invite

Sze T. Lee — researcher profile on SciRah

Eliza A. Hawkes×9

Invite

Eliza A. Hawkes — researcher profile on SciRah

Invite

A. Grigg — researcher profile on SciRah

Invite

T. Cochrane — researcher profile on SciRah

D. Talaulikar×8

Invite

D. Talaulikar — researcher profile on SciRah

Invite

K. Manos — researcher profile on SciRah

Invite

G. Hapgood — researcher profile on SciRah